Left Ventricular Hypertrophy Daniel Levy Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 1 - 5
Factors Involved in the Pathogenesis of Hypertensive Cardiovascular Hypertrophy Björn Dahlöf Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 6 - 26
Left Ventricular Hypertrophy and Antihypertensive Therapy Franz H. MesserliShmuel OrenEhud Grossman Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 27 - 33
Heterogeneity of Response of Peripheral Arteries to Antihypertensive Drugs in Essential Hypertension Jaime LevensonAlain Simon Section 1: Cardiovascular Hypertrophy 18 October 2012 Pages: 34 - 39
Aspects of the Role of Intraglomerular Pressure as a Cause of Progressive Renal Damage Mattias Aurell Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 42 - 47
Proteinuria as a Prognostic Factor during Long Term Hypertensive Care O. Samuelsson Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 48 - 54
Renal Function before and after Withdrawal of Long Term Antihypertensive Treatment in Primary Hypertension Susanne LjungmanMattias AurellGöran Berglund Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 55 - 58
Effects of Antihypertensive Therapy on Kidney Function in Diabetic Patients Bengt Scherstén Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 59 - 61
Renal Protective Effect of Long Term Antihypertensive Therapy with Enalapril John H. BauerGarry P. Reams Section 2: The Pathogenic Role of the Kidney 18 October 2012 Pages: 62 - 71
Quality of Life under Antihypertensive Treatment James A. Schoenberger Section 3: Quality of Life 18 October 2012 Pages: 74 - 79
Memory Function — Effects of Different Antihypertensive Drugs P. J. RichardsonM. A. Wyke Section 3: Quality of Life 18 October 2012 Pages: 80 - 85
Evaluation of Mood and the Effect of Angiotensin-Converting Enzyme Inhibitors Sverker Jern Section 3: Quality of Life 18 October 2012 Pages: 86 - 88
Safety Profiles of the Angiotensin-Converting Enzyme Inhibitors Natalie J. WarnerJanet E. Rush Section 3: Quality of Life 18 October 2012 Pages: 89 - 97